Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

China flag China · Delayed Price · Currency is CNY
4.880
+0.050 (1.04%)
Aug 4, 2026, 3:04 PM CST
Market Cap3.99B -24.5%
Revenue (ttm)812.78M +2.7%
Net Income-95.15M
EPS-0.12
Shares Out 816.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,908,200
Open4.830
Previous Close4.830
Day's Range4.830 - 4.950
52-Week Range4.060 - 8.630
Beta0.09
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:300318

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of in-vitro diagnostic products in China and internationally. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; human serum albumin; human prothrombin complex and human coagulation factor VIII; and vaccine for rabies. It also provides molecular diagnostics platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2,170
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300318
Full Company Profile

Financial Performance

Financial Statements